Celgene Corp (CELG) Misses Q4 EPS by 1c, Sales Fall Just Short

January 26, 2012 7:38 AM EST
Celgene Corp (NASDAQ: CELG) reported Q4 EPS of $1.05, $0.01 worse than the analyst estimate of $1.06. Revenue for the quarter came in at $1.24 billion versus the consensus estimate of $1.29 billion.

For earnings history and earnings-related data on Celgene Corp (CELG) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings